Influence of donor capnometry on renal graft evolution in uncontrolled donation after circulatory death

Resuscitation. 2023 Aug:189:109863. doi: 10.1016/j.resuscitation.2023.109863. Epub 2023 Jun 9.

Abstract

Aim: To analyse the association between donor capnometry data and the short-term evolution of kidney grafts in cases of uncontrolled donation after circulatory death (uDCD).

Method: We used an ambispective observational study design, conducted in the Community of Madrid between January and December 2019, inclusive. Patients who suffered out-of-hospital cardiac arrest (CA) with no response to advanced cardiopulmonary resuscitation (CPR) were selected as potential donors. Donor capnometry levels were measured at the start, midpoint and transfer to hospital then compared with indicators of renal graft evolution.

Results: The initial selection included 34 possible donors, of which 12 (35.2%) were viable donors from whom 22 (32.3%) kidneys were recovered. There was a correlation between the highest capnometry values and less need for post-transplant dialysis (≥24 mmHg, p < 0.017), fewer dialysis sessions and fewer days to recover correct renal function (Rho -0.47, p < 0.044). There was a significant inverse correlation between the capnometry values at transfer and 1-month post-transplant creatinine levels (Rho -0.62, p < 0.033). There were no significant differences between the capnometry values at transfer and primary nonfunction (PNF) or warm ischaemia time. One-year patient survival was 100% for patient receiving organ donation, while graft survival was 95%.

Conclusions: Capnometry levels at transfer are a useful predictor of the short-term function and viability of kidney transplants from uncontrolled donations after circulatory death.

Keywords: Asystole; Capnometry; Emergency medical services; Kidney transplant; Resuscitation.

Publication types

  • Observational Study

MeSH terms

  • Death
  • Graft Survival
  • Humans
  • Kidney
  • Kidney Transplantation*
  • Organ Transplantation*
  • Tissue Donors
  • Tissue and Organ Procurement*